Endogenous sex hormones are not assodated with subclinical atherosclerosis in menopausal women

Minerva Ginecologica

Volumn 65, Issue 3, 2013, Pages 297-302

  Celestino Catao Da Silva D ^a   Nogueira De Almeida Vasconcelos, A ^a   Cleto Maria Cerqueira, J ^a   De Oliveira Cipriano Torres, D ^a   Oliveira Dos Santos, A C ^a   De Lima Ferreira Fernandes Costa, H ^a   Bregieiro Fernandes Costa, L O ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Cardiovascular diseases; Carotid intima media thickness; Estradiol; Menopause; Testosterone

Indexed keywords

ESTRADIOL; INSULIN; SEX HORMONE; TESTOSTERONE;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY FAT DISTRIBUTION; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; TESTOSTERONE BLOOD LEVEL; ULTRASOUND; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; AGED; ATHEROSCLEROSIS; BODY FAT DISTRIBUTION; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; TESTOSTERONE; TIME FACTORS;

EID: 84882396868     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Van Der Schouw YT. Incidence and mortality of cardiovascular disease in postmenopausal women worldwide and relevance for preventive strategies. Climacteric 2009;12(Suppl 1):1-5.
2. Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: long-term health consequences. Maturitas 2010;65:161-6.
3. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007;115:459-67.
4. Mancini GB, Dahlof B, Diez J. Surrogate markers for cardiovascular disease: structural markers. Circulation 2004;109(25 Suppl 1): IV22-30.
5. Golden SH, Maguire A, Ding J, Crouse JR, Cauley JA, Zacur H et al. Endogenous postmenopausal hormones and carotid atherosclerosis: a case control study of the atherosclerosis risk in communities cohort. Am J Epidemiol 2002;155:437-45.
6. Rexrode KM, Manson JE, Lee IM, Ridker PM, Sluss PM, Cook NR et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 2003;108:1688-93.
7. Karim R, Hodis HN, Stanczyk FZ, Lobo RA, Mack WJ. Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab 2008;93:131-8.
8. Lee JS, Yaffe K, Lui LY, Cauley J, Taylor B, Browner W et al. Study of Osteoporotic Fractures Group. Prospective study of endogenous circulating estradiol and risk of stroke in older women. Arch Neurol 2010;67:195-201.
9. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96:1432-7.
10. Knapp RH. Estrogen, female gender, and heart disease. In: Topol EJ editor. Textbook of cardiovascular medicine. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 195-218.
11. Wu MM, Hsieh YC, Lien LM, Chen WH, Bai CH, Chiu HC et al. Association of estrogen receptor {alpha} genotypes/haplotypes with carotid intima-media thickness in Taiwanese women. Angiology 2010;6:275-82.
12. Lisowska A, Musiai WJ, Knapp M, Prokop J, Dobrzycki S. Carotid and femoral atherosclerotic lesions in patients with coronary heart disease confirmed by angiography. Kardiol Pol 2005;63:636-42.
13. nd edition. Philadelphia, PA: J B Lippincott Company; 1995. p. 915-24.
14. Wildman RP, Colvin AB, Powell LH, Matthews KA, Everson-Rose SA, Hollenberg S et al. Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN). Menopause 2008;15:4l4-21.
15. Kiechl S, Willeit J. The natural course of atherosclerosis. Part II: vascular remodeling. Bruneck study group. Arterioscler Thromb Vasc Biol 1999;19:1491-8.
16. Debing E, Peeters E, Duquet W, Poppe K, Velkeniers B, Van Den Brande P. Endogenous sex hormone levels in postmenopausal women undergoing carotid artery endarterectomy. Eur J Endocrinol 2007;156:687-93.
17. Bernini GP, Sgro M, Moretti A, Argenio GF, Barlascini CO, Cristofani R, Salvetti A. Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab 1999;84:2008-12.
18. Brand JS, Van Der Schouw YT. Testosterone, SHBG and cardiovascular health in postmenopausal women. Int J Impot Res 2010;22:91-104.
19. Calderon-Margalit R, Schwartz SM, Wellons MF, Lewis CE, Daviglus ML, Schreiner PJ et al. Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: the "Coronary Artery Risk Development in Young Adults" women's study. J Clin Endocrinol Metab 2010;95:4424-31.
20. Maturana MA, Breda V, Lhullier F, Spritzer PM. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. Metabolism 2008;57:961-5.
21. Creatsa M, Armeni E, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M et al. Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women. Metabolism 2012;61:193-201.
22. Barrett-Connor E, Goodman-Gruen D. Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study. Circulation 1995;91:1757-60.
23. Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S et al. INTERHEART Investigators in Latin America. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation 2007;115:1067-74.
24. Bell RJ, Davison SL, Papalia MA, McKenzie DP, Davis SR. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span. Menopause 2007;14:630-8.
25. Mesch VR, Siseles NO, Maidana PN, Boero LE, Sayegh F, Prada M et al. Androgens in relationship to cardiovascular risk factors in the menopausal transition. Climacteric 2008;11:509-17.
26. Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 2009;42:1331-46.
27. Civera M, Urios A, Garcia-Torres ML, Ortega J, Martinez-Valls J, Cassinello N et al. Relationship between insulin resistance, inflammation and liver cell apoptosis in patients with severe obesity. Diabetes Metab Res Rev 2010;26:187-92.
28. Ingelsson E, Hulthe J, Lind L. Inflammatory markers in relation to insulin resistance and the metabolic syndrome. Eur J Clin Invest 2008;38:502-9.
29. Park HW, Kown TG, Kim KY, Bae JH. Diabetes, insulin resistance and atherosclerosis surrogates in patients with coronary atherosclerosis. Korean Circ J 2010;40:62-7.
30. Mack WJ, Slater CC, Xiang M, Shoupe D, Lobo RA, Hodis HN. Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause. Fertil Steril 2004;82:391-7.